These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Octahedral copper(ii)-diimine complexes of triethylenetetramine: effect of stereochemical fluxionality and ligand hydrophobicity on Cu Sharma M; Ganeshpandian M; Majumder M; Tamilarasan A; Sharma M; Mukhopadhyay R; Islam NS; Palaniandavar M Dalton Trans; 2020 Jun; 49(24):8282-8297. PubMed ID: 32510543 [TBL] [Abstract][Full Text] [Related]
3. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity. Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978 [TBL] [Abstract][Full Text] [Related]
4. New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents. Icsel C; Yilmaz VT; Aydinlik Ş; Aygun M Eur J Med Chem; 2020 Sep; 202():112535. PubMed ID: 32653697 [TBL] [Abstract][Full Text] [Related]
5. Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis. Icsel C; Yilmaz VT; Aydinlik S; Aygun M Dalton Trans; 2020 Jun; 49(23):7842-7851. PubMed ID: 32463408 [TBL] [Abstract][Full Text] [Related]
7. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity. Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives. Liang JW; Wang Y; Du KJ; Li GY; Guan RL; Ji LN; Chao H J Inorg Biochem; 2014 Dec; 141():17-27. PubMed ID: 25172994 [TBL] [Abstract][Full Text] [Related]
9. Novel binuclear and trinuclear metal (II) complexes: DNA interactions and in vitro anticancer activity through apoptosis. Zhao Z; Zhang J; Zhi S; Song W; Zhao J J Inorg Biochem; 2019 Aug; 197():110696. PubMed ID: 31103889 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, interaction with DNA and antiproliferative activities of two novel Cu(II) complexes with norcantharidin and benzimidazole derivatives. Song WJ; Lin QY; Jiang WJ; Du FY; Qi QY; Wei Q Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():122-8. PubMed ID: 25218220 [TBL] [Abstract][Full Text] [Related]
11. Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine. Li L; Du K; Wang Y; Jia H; Hou X; Chao H; Ji L Dalton Trans; 2013 Aug; 42(32):11576-88. PubMed ID: 23843095 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes. Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453 [TBL] [Abstract][Full Text] [Related]
13. Cu(II)-dipeptide complexes of 2-(4'-thiazolyl)benzimidazole: synthesis, DNA oxidative damage, antioxidant and in vitro antitumor activity. Fu XB; Zhang JJ; Liu DD; Gan Q; Gao HW; Mao ZW; Le XY J Inorg Biochem; 2015 Feb; 143():77-87. PubMed ID: 25528481 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate. Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198 [TBL] [Abstract][Full Text] [Related]
15. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism. Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995 [TBL] [Abstract][Full Text] [Related]
16. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes. Anjomshoa M; Torkzadeh-Mahani M Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of copper(II) complexes of imidazole derivatives. Li X; Chen K; Lai J; Wang S; Chen Y; Mo X; Chen Z J Inorg Biochem; 2024 Nov; 260():112690. PubMed ID: 39126756 [TBL] [Abstract][Full Text] [Related]
18. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells. Paul A; Singh P; Kuznetsov ML; Karmakar A; Guedes da Silva MFC; Koch B; Pombeiro AJL Dalton Trans; 2021 Mar; 50(10):3701-3716. PubMed ID: 33634805 [TBL] [Abstract][Full Text] [Related]
19. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents. Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010 [TBL] [Abstract][Full Text] [Related]